Even Dim Bedroom Light Is Linked to Poorer Sleep in Schizophrenia, Study Finds

Sleep disturbances are among the most persistent and disabling complaints reported by people living with schizophrenia, and a new study from Japan suggests that an everyday environmental factor—the amount of light present in the bedroom at night—may be quietly making things worse. Researchers at Fujita Health University School of Medicine, working with colleagues at Okehazama Hospital, analyzed detailed sleep and light-exposure data from 225 adult outpatients with schizophrenia and found that those exposed to higher levels of nighttime illumination slept less, slept less efficiently, and spent more time awake after initially falling asleep. The work, conducted as part of the Light Exposure and Neurobiology in Schizophrenia (LENS) study, was published online on June 23, 2026, and will appear in Volume 364 of the journal Psychiatry Research on October 1, 2026.

The relationship between light and sleep is rooted in fundamental human biology. The suprachiasmatic nucleus of the hypothalamus, the body’s master circadian clock, receives direct input from specialized retinal cells that are particularly sensitive to short-wavelength blue light. Evening and nighttime exposure to this light suppresses melatonin secretion from the pineal gland, delays circadian phase, and increases alertness at precisely the hours when the brain should be winding down. In the general population, these effects are well documented, and sleep hygiene guidelines routinely recommend dark, quiet bedrooms. What had been missing, the researchers note, is evidence specifically addressing whether nighttime light is associated with sleep quality in schizophrenia—a population in which circadian rhythm abnormalities, medication effects, and lifestyle factors all complicate the picture.

To fill that gap, the team designed a study that combined objective and subjective measurement in a way few investigations in this population have done. Each participant wore a wrist actigraphy device continuously for seven days. Actigraphy uses an accelerometer to detect movement, allowing researchers to estimate sleep onset, sleep offset, total sleep time, sleep efficiency, sleep onset latency, and wakefulness after sleep onset without relying on a patient’s recall. Because people with schizophrenia may have difficulty accurately reporting their own sleep, this objective component carries particular weight.

The researchers did not stop at the wrist, however. A portable photometer was placed beside each participant’s bed to independently measure ambient nighttime illuminance in lux, providing an environmental reading separate from the light that might reach the actigraphy sensor itself. Participants also kept a sleep diary recording bedtime and rising time, and subjective sleep quality was assessed with the Pittsburgh Sleep Quality Index, a widely used questionnaire covering sleep over the previous month. Median nighttime illuminance was 1.4 lux as measured by actigraphy and 4.1 lux as measured by the bedside photometer—levels far below ordinary indoor lighting but comparable to a dim nightlight or light leaking through curtains from streetlamps.

After statistically adjusting for a long list of potential confounders—including age, sex, smoking status, body mass index, psychiatric symptom severity, daytime light exposure, sleep timing, day length, and medications—the differences between light-exposure groups were striking. Compared with participants in the lowest nighttime-light group, those in the highest group showed 10 percent lower sleep efficiency, slept 55.6 minutes less in total, took longer to fall asleep, and spent 31 minutes more awake after sleep onset. Higher exposure to blue light specifically showed similar associations, consistent with the known sensitivity of the circadian system to short wavelengths.

One of the most intriguing findings is what the study did not show. The Pittsburgh Sleep Quality Index, which asked patients to rate their sleep over the preceding month, revealed no significant association with nighttime light. The researchers offer two possible explanations. First, some patients may experience objectively poorer sleep without fully recognizing it, a dissociation between perceived and measured sleep that has been described in other clinical populations. Second, the two measurement windows differ: the questionnaire retrospectively covers a month, while actigraphy and light measurements were collected prospectively over just seven days, a design that reduces recall bias but captures a shorter slice of life.

“Our findings suggest that even relatively low levels of nighttime light may be linked to measurable sleep disruption in people with schizophrenia,” said Mr. Ryota Miyake, a student researcher in the Department of Psychiatry at Fujita Health University School of Medicine who led the work with Dr. Yuichi Esaki, alongside Dr. Nakao Iwata, Dr. Tsuyoshi Kitajima, and Dr. Kiyoshi Fujita of Okehazama Hospital.

The clinical implications could be significant precisely because the exposure is so easy to modify. Poor sleep in schizophrenia is not a trivial side complaint: it is associated with worse quality of life, more severe psychiatric symptoms, impaired cognition, and reduced daily functioning, and it may contribute to relapse risk. Current management often leans on sedating medications, which carry their own burden of daytime drowsiness, metabolic effects, and drug interactions. If darker bedrooms genuinely improve sleep, a simple environmental adjustment—dimming screens, blocking streetlight with blackout curtains, or eliminating unnecessary nightlights—could offer a low-cost, nonpharmacological complement to existing treatment.

The authors are careful, however, to frame the results as an association rather than proof of cause and effect. The study was cross-sectional, meaning light exposure and sleep were measured at the same time, so it cannot determine whether light disrupts sleep or whether some other factor—such as underlying circadian dysfunction, greater nighttime activity, or differences in living environment—drives both. People who sleep poorly may also get up during the night and turn on lights, reversing the presumed direction of the relationship. Prospective intervention studies, in which bedrooms are deliberately darkened and sleep is tracked before and after, will be needed to establish causality.

“Optimizing the nighttime light environment could become an important part of sleep hygiene if future longitudinal and intervention studies confirm these findings,” said Mr. Miyake. If those trials succeed, the consequences could extend well beyond individual bedrooms. Lighting practices in psychiatric hospitals, group homes, and residential care facilities could be redesigned to protect patients’ sleep, potentially improving symptoms and daytime functioning while reducing reliance on additional sedating drugs. For now, the study stands as a reminder that the environment surrounding a sleeping person is not neutral—and that for one of psychiatry’s most vulnerable populations, even a few lux of stray light may be one factor worth taking seriously.

Subject of Research: The association between nighttime light exposure and objectively measured sleep parameters in outpatients with schizophrenia

Article Title: Nighttime light may disrupt sleep in people with schizophrenia

Article References: Nighttime light may disrupt sleep in people with schizophrenia. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: schizophrenia, sleep, nighttime light, actigraphy, circadian rhythm, sleep efficiency, blue light, Psychiatry Research, Fujita Health University, sleep hygiene, melatonin, observational study